secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001493152-23-038372
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics reports conversion of $1.32M debentures into 7.3M shares
---------------------------------------------------------------------------

- Holders converted $1,322,200 of Original Issue Discount Senior Convertible Debentures at $0.18/share.
- Company issued 7,300,342 shares of common stock between Oct 20-25, 2023.
- Outstanding shares increased from 44,231,402 to 51,531,744, a dilution of ~16.5%.
- No cash proceeds were received; debt was extinguished upon conversion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315223038372/0001493152-23-038372-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315223038372/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038372

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer